|
About Cetek • Management • Board
of Directors • Scientific Advisory
Board • Investors
Management Team
Cetek’s
management team has a strong track record in drug discovery and development
and in building discovery and development companies.
James L. Waters, Chairman
- Formerly Chairman, President and Founder of Waters
Corporation, Founder of or Investor in many successful technology
based companies.
Barry A. Berkowitz, Ph.D., President and CEO
- Formerly, founder and CEO of New Chemical Entities,
Inc. (sold to Albany Molecular Research, Inc.); ChemGenics Pharmaceuticals,
Inc. (sold to Millennium Pharmaceuticals) and Magainin Pharmaceuticals,
Inc. (now Genaera Corporation). He also held research and development executive
positions at SmithKline & French (now Glaxo SmithKline) and research positions
at the Roche Institute of Molecular Biology.
Dallas E. Hughes, Ph.D., Senior
Vice President, Technology; Founder
- Previously Director of Biological Research at
Exogene Corporation. Scientist at Barnett Institute, Northeastern
University.
Herbert J. Hedberg,
Senior Vice President, Operations
- Formerly, founder and President, Firmware Resources, Inc., founder and Vice President, Autochrom, Inc., Vice President, Sweet Micro Systems, Inc., and Senior Product Development Manager at Waters Corporation.
Vincent P.
Gullo, Ph.D., Vice President, Drug Discovery
- Previously Senior
Director of New Lead Discovery at Schering-Plough Research Institute
and Research Fellow in Natural Product Chemistry at Merck Research
Laboratories.
Gerhard J. Sperl, Ph.D.,
Vice President, Medicinal Chemistry
- Previously Vice President of Chemistry, Manufacturing
and Controls at Point Therapeutics, Inc., Director of Preclinical
Development at ArQule, Inc., and Senior Director of Chemistry and
Screening group at Cell Pathways, Inc.
Robert Morgan, Vice President,
Chief Financial Officer
- Previously Senior Vice President of Flagship Ventures
and Co-Founder of NewcoGen Group; founder or senior executive
at numerous companies, including ChemGenics Pharmaceuticals,
Inc. (sold to Millennium Pharmaceuticals), Enzytech, Inc. (sold
to Alkermes), Opta Food Ingredients (sold to Stake Technologies),
and others.
|
